Targeting the Checkpoint Receptor TIGIT via CRISPR/Cas9 Genome Editing to Enhance NK Cell Anti-Tumor Activity |
Research Institute at Nationwide Children's Hospital / Amanda Campbell, MD/PhD |
Young Investigator Grants |
2023 |
Ohio |
CDK8 as a New Therapeutic Target in Alveolar Rhabdomyosarcoma |
Dana-Farber Cancer Institute / Susu Zhang, PhD |
Young Investigator Grants |
2023 |
Massachusetts |
Stapled Oncolytic Peptides for Treatment-Resistant Pediatric Leukemias |
Dana-Farber Cancer Institute / Loren Walensky, MD, PhD |
Innovation Grants |
2023 |
Massachusetts |
Targeting Chromatin Remodeling Complexes for Rhabdomyosarcoma (RMS) Therapy |
Dana-Farber Cancer Institute / Jun Qi, PhD |
Innovation Grants |
2023 |
Massachusetts |
Modulation of STING to enhance the efficacy of treatments for diffuse midline glioma |
Duke University / Zachary Reitman, MD/PhD |
'A' Award Grants |
2023 |
North Carolina |
Feasibility Study of Dual Inhibition of MDM2 and Tubulin in Treatment of AML |
Emory University / Muxiang Zhou, MD |
Reach Grants |
2023 |
Georgia |
Desmoplastic Small Round Cell Tumors: Investigation of its Pathogenesis and Development of Novel Therapies |
Memorial Sloan-Kettering Cancer Center / Andrea Ventura, MD, PhD |
Innovation Grants |
2023 |
New York |
Pre-Targeted Radioimmunotherapy for Desmoplastic Small Round Cell Tumors |
Memorial Sloan-Kettering Cancer Center / Madelyn Espinosa-Cotton, PhD |
Young Investigator Grants |
2023 |
New York |
Ex Vivo Modeling of Medulloblastoma using Human iPSC-Derived Cerebellar Organoids |
St. Jude Children’s Research Hospital / Stephanie Wu, PhD |
Young Investigator Grants |
2023 |
Tennessee |
Mutagenesis and disease progression in RUNX1 mutant blood stem cells is caused by inflammation-induced hyperactive signaling and supraphysiological mitochondrial ROS |
St. Jude Children’s Research Hospital / Dirk Loeffler, PhD |
RUNX1 Early Career Investigator Grants |
2023 |
Tennessee |